New Studies Give Mixed Results About Taking Fish Oil and Vitamin D
(CHICAGO) — Taking fish oil or vitamin D? Big studies give long-awaited answers on who does and does not benefit from these popular nutrients. Fish oil taken by healthy people, at a dose found in many supplements, showed no clear ability to lower heart or cancer risks. Same for vitamin D. But higher amounts of a purified, prescription fish oil slashed heart problems and heart-related deaths among people with high triglycerides, a type of fat in the blood, and other risks for heart disease. Doctors cheered the results and said they could suggest a new treatment option for hundreds of thousands of patients like these. ...
Source: TIME: Health - November 10, 2018 Category: Consumer Health News Authors: MARILYNN MARCHIONE / AP Tags: Uncategorized onetime Supplements Source Type: news

Prescription Doses of Fish Oil May Lower Heart Attack and Stroke Risk
Omega-3 fatty acids, abundant in fish oil, are known to be good for the heart. Studies have shown that people who eat more fish rich in these fats have lower rates of heart problems and less risk of dying from heart disease compared to those who eat less. Those data have fueled a booming business in over-the-counter fish oil supplements. In a new study published in the New England Journal of Medicine, and presented at the American Heart Association annual meeting, researchers report that a highly purified version of omega-3 fats, called icosapent ethyl, can lower the risk of a number of heart-related events, including hear...
Source: TIME: Health - November 10, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime Heart Disease omega-3 Source Type: news

AHA: Revised Lipid Guide Boosts PCSK9s, Coronary Calcium Scans
(MedPage Today) -- New recommendations aim to cut statins in low-risk primary prevention (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 10, 2018 Category: American Health Source Type: news

Statins may prevent the spread of breast cancer to other organs, study finds
A new study from the University of Pittsburgh Medical Center has found that statins can prevent breast cancer tumors from migrating to the lungs and liver, potentially saving lives. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2018 Category: Consumer Health News Source Type: news

Nonadherence, Discontinuation of Statins High in 1st Year of Rx
WEDNESDAY, Nov. 7, 2018 -- First-year nonadherence and discontinuation are high among older adults prescribed statins, according to a study published online Nov. 7 in the British Journal of Clinical Pharmacology. Richard Ofori-Asenso, from Monash... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 7, 2018 Category: Pharmaceuticals Source Type: news

Nearly half of over-65s who take statins give them up within a year due to side effects, study shows
Side effects - like risk of diabetes, erectile dysfunction, sleep problems and muscle pain- are putting off 45 per cent of over-65s within 12 months, the study shows. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2018 Category: Consumer Health News Source Type: news

Study explores timing of muscle-related problems of statin use
(Wiley) Statins have been linked with muscle pain and other musculoskeletal adverse events (MAEs) in some patients. A new Pharmacology Research& Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2018 Category: International Medicine & Public Health Source Type: news

Many older adults do not take prescribed statins properly
(Wiley) In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2018 Category: International Medicine & Public Health Source Type: news

Ovarian Ca Risk Reduced with Postmenopausal Statins
(MedPage Today) -- All histologic types of ovarian cancer risk lowered in statin versus non-statin users (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 6, 2018 Category: Cardiology Source Type: news

Statin cost effective for CVD prevention in T2DM in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2018 Category: Drugs & Pharmacology Source Type: news

Link Between Statins, Non-CVD Outcomes Lacks Evidence
WEDNESDAY, Oct. 31, 2018 -- There is a lack of convincing evidence for an association between statin use and non-cardiovascular disease (CVD) outcomes, according to a review published in the Oct. 16 issue of the Annals of Internal Medicine. Yazhou... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2018 Category: Pharmaceuticals Source Type: news

Is there a connection between statins and memory loss?
(Natural News) Statins are quickly becoming one of the most controversial drugs on the market. Experts say that there are millions of people being prescribed these hazardous drugs for no reason. Pharmaceutical dogma is so deeply ingrained that many people without heart disease are prescribed statins as a “preventive” measure — even though the side... (Source: NaturalNews.com)
Source: NaturalNews.com - October 30, 2018 Category: Consumer Health News Source Type: news

Bempedoic Acid Clears Phase III as Statin Booster
(MedPage Today) -- Top-line results show additional LDL lowering, but outcomes data not due until 2022 (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 29, 2018 Category: Cardiology Source Type: news

Australian watchdog's appeal against Pfizer ruling dismissed by court
Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Court dismisses Australian watchdog's appeal against Pfizer ruling
Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Undiagnosed Diseases; TDAP and Pregnancy: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include undiagnosed diseases, sexual assault and mental and physical health in women, timing of TDAP in pregnancy, and statins beyond cardiovascular disease. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 13, 2018 Category: Infectious Diseases Source Type: news

Oct 12, 2018 This Week in Cardiology Oct 12, 2018 This Week in Cardiology
Timing of aortic valve replacement, rivaroxaban failure post TAVR, statins beyond CVD, conflicts of interest, and post-stent antithrombotic management are discussed in this week ’ s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Exercise and Cancer; Smarter Mammography; Statins, Vitamin D, Keto, and Cancer
(MedPage Today) -- News, features, and commentary about cancer-related issues (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 11, 2018 Category: American Health Source Type: news

Statins Show Little Evidence of Benefit in Non-CVD Conditions Statins Show Little Evidence of Benefit in Non-CVD Conditions
Despite growing interest in the use of statins for conditions unrelated to the heart, a rigorous analysis finds no strong support for their benefit beyond cardiovascular protection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 10, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Jury Still Out on Statins' Benefit Beyond the Heart
(MedPage Today) -- Review finds suggestive evidence insufficient to move practice (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 9, 2018 Category: Respiratory Medicine Source Type: news

Evidence does NOT support statin use for conditions other than heart disease
Researchers from the University of Edinburgh argue there is insufficient evidence to support statins being prescribed for non-cardiovascular conditions such as cancer and Alzheimer's. (Source: the Mail online | Health)
Source: the Mail online | Health - October 8, 2018 Category: Consumer Health News Source Type: news

Statins' benefits beyond heart health aren't clear-cut, analysis says
Despite some studies suggesting that statin drugs have benefits beyond cardiovascular health, for such issues as cancer and Alzheimer's, a broad new analysis says there's a lack of compelling evidence linking such benefits to statins -- and, thus, little reason to change recommendations for who gets these cholesterol-lowering meds and why. (Source: CNN.com - Health)
Source: CNN.com - Health - October 8, 2018 Category: Consumer Health News Source Type: news

Evidence does not support statin use for conditions other than heart disease
(American College of Physicians) Despite studies suggesting benefits for conditions beyond cardiovascular disease (CVD), the evidence does not support revising current statin prescribing guidelines. Findings from an evidence review and meta-analysis are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2018 Category: Cancer & Oncology Source Type: news

Statins show little promise for conditions other than heart disease
(University of Edinburgh) Medicines commonly prescribed to reduce people's risk of heart attack may have limited use for treating other diseases, research suggests. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2018 Category: Cancer & Oncology Source Type: news

Ask Well: Does Coenzyme Q10 Reduce Statin-Related Muscle Aches?
Studies have provided mixed results. (Source: NYT Health)
Source: NYT Health - October 5, 2018 Category: Consumer Health News Authors: RICHARD KLASCO, M.D. Tags: Muscles Drugs (Pharmaceuticals) Statins (Cholesterol-Lowering Drugs) Dietary Supplements and Herbal Remedies Source Type: news

Medical News Today: Does 'bad' cholesterol deserve its bad name?
A new study challenges the long-held belief that low-density lipoprotein cholesterol causes heart disease, and that statins benefit cardiovascular health. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 2, 2018 Category: Consumer Health News Tags: Cholesterol Source Type: news

Statins and Osteoporosis, Fracture Risks in Stroke Patients Statins and Osteoporosis, Fracture Risks in Stroke Patients
Could daily doses of statins help prevent osteoporosis and bone fractures after a stroke?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 1, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

The effects of statin therapy on mortality in patients with sepsis: A meta-analysis of randomized trials.
This systematic review and meta-analysis of randomized trials aimed to evaluate the clinical efficacy of statin therapy on mortality from sepsis. It concludes that statin therapy has no effect on mortality outcomes in patients with sepsis compared with placebo. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 28, 2018 Category: Consumer Health News Source Type: news

Statins, Fibrates Lower Diabetic Retinopathy Risks in Diabetes Statins, Fibrates Lower Diabetic Retinopathy Risks in Diabetes
Patients with type 2 diabetes given statin or fibrate lipid-lowering therapy have both a reduced risk of developing diabetic retinopathy and being treated for the condition, Japanese claims data show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Fish Oil Drug May Prevent Heart Attack and Strokes in High-Risk Patients
Large doses of an omega-3 fatty acid in fish oil sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes. (Source: NYT Health)
Source: NYT Health - September 26, 2018 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Heart Omega-3 Fatty Acids Diabetes Statins (Cholesterol-Lowering Drugs) Amarin Corp PLC Source Type: news

Can Fish Oil Cut Danger of High-Risk Heart Issues?
The researchers focused on people whose cholesterol levels were controlled with statins, but whose triglyceride levels were still high. Because many smaller studies had not produced much evidence of any benefit in adding fish oil supplements to statin use, the hopes of heart experts were not high. (Source: WebMD Health)
Source: WebMD Health - September 25, 2018 Category: Consumer Health News Source Type: news

Fish Oil Drug May Reduce Heart Attack and Stroke Risks for Some
Large doses of an omega-3 fatty acid in fish oil sharply reduced the rate of cardiovascular events in people with a history of heart disease or Type 2 diabetes. (Source: NYT Health)
Source: NYT Health - September 25, 2018 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Heart Omega-3 Fatty Acids Diabetes Statins (Cholesterol-Lowering Drugs) Amarin Corp PLC Source Type: news

One million warned over side effects from mixing drugs and herbal remedies
Doctors stressed that statins, diabetes drugs and stomach acid pills can interact negatively with popular health supplements. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2018 Category: Consumer Health News Source Type: news

Sep 21, 2018 This Week in Cardiology Sep 21, 2018 This Week in Cardiology
ASA, polypharmacy, statins and obesity treatments are the topics discussed by Dr John Mandrola in this week ’ s podcasttheheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

CV Risk in Hypertriglyceridemic Patients With LDL-C Control CV Risk in Hypertriglyceridemic Patients With LDL-C Control
Elevated triglyceride levels may contribute to a greater risk for cardiovascular disease despite statin-controlled LDL cholesterol levels.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Study: Drug combo could reduce heart attack risk
A combination of drugs being developed that lower triglycerides levels and approved statins that reduce cholesterol levels may reduce heart attack risk. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 20, 2018 Category: Consumer Health News Source Type: news

Statins Improve Long-Term Survival After AAA Repair
THURSDAY, Sept. 20, 2018 -- Preoperative statin therapy is associated with higher long-term survival following abdominal aortic aneurysm (AAA) repair, according to a study published in the August issue of the Journal of Vascular Surgery. Thomas F.X.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2018 Category: Pharmaceuticals Source Type: news

New drugs could reduce risk of heart disease when added to statins
New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins, according to new research conducted by MRC scientists. (Source: Medical Research Council General News)
Source: Medical Research Council General News - September 20, 2018 Category: Research Source Type: news

Statin Benefits After 75 Limited to Patients With Diabetes Statin Benefits After 75 Limited to Patients With Diabetes
Analysis of NHANES data showed no overall benefit of statins for primary prevention, with the exception of adults with type 2 diabetes, and only for those aged 75 to 84 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Give millions of patients already on statins a new type of drug
Cambridge University researchers tested the effects of LPL enhancers using genetic data of around 400,000 people. The results were published in JAMA Cardiology. (Source: the Mail online | Health)
Source: the Mail online | Health - September 19, 2018 Category: Consumer Health News Source Type: news

Statins use ‘of doubtful benefit’
THERE is no evidence that high levels of “bad” cholesterol cause heart disease and the widespread use of statins is “of doubtful benefit”, according to a study by 17 international physicians. (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2018 Category: Consumer Health News Source Type: news

Daily aspirin not beneficial in healthy adults
Trial looks at risks and benefits of aspirin Related items fromOnMedica Too few women take part in many CVD clinical trials US doctor says FDA should have withdrawn rosuvastatin GPs defend practice on prescribing statins Drugs regulators “put profits before patients” Withdrawn valsartan meds not linked to short-term cancer risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 17, 2018 Category: UK Health Source Type: news

Paying People To Lower Their Cholesterol Works But Is It Cost-Effective?
Offering financial rewards to patients who lower their bad cholesterol by adhering to statin regimens could help prevent heart disease, but there are lingering questions about whether such a strategy is worth the added healthcare costs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 14, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

Are fungi the secret to a sweet sounding violin? – Science Weekly podcast
From making violins sound beautiful, to beer and bread, to creating life-saving medicine, fungi have an array of very useful attributes. This week, a report demonstrates just how little we know about this kingdom of life and what we are set to gain if we tap into fungi as a resource.Hannah Devlin investigates.Join the discussion onFacebook andTwitterThe more mycologists study fungi, the more they ’re beginning to realise what an intriguing kingdom of life it is. Life-saving drugs like statins, penicillin and the immunosuppressants used in organ donation are all derived from fungi, as is the yeast used in bread and be...
Source: Guardian Unlimited Science - September 14, 2018 Category: Science Authors: Presented by Hannah Devlin and produced by Graihagh Jackson Tags: Science Environment Fungi Music Source Type: news

Is crowdfunding for cancer patients paying for ‘quackery’?
Since 2012 appeals on UK crowdfunding sites for alternative cancer ‘treatment’ have raised £8m Related items fromOnMedica Cancer patients using complementary meds die sooner GPs defend practice on prescribing statins The NHS must adapt now to care for older cancer patients Exercise and psychological treatments cut cancer fatigue Antibiotic scrip rates lower in CAM-trained practices (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 14, 2018 Category: UK Health Source Type: news

Withdrawn valsartan meds not linked to short-term cancer risk
Expedited analysis of NDMA-contaminated products finds no markedly raised short-term cancer risk Related items fromOnMedica GPs defend practice on prescribing statins Too few women take part in many CVD clinical trials MHRA tightens licence restrictions on valproate for women Cancer patients using complementary meds die sooner Drugs regulators “put profits before patients” (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 13, 2018 Category: UK Health Source Type: news

Psychological well-being linked to better cardiovascular outcomes
Doctors should have patient-centred discussions on how to promote psychological well-being Related items fromOnMedica GPs defend practice on prescribing statins Health professionals vary hugely in disability assessments GPs should advise exercise for patients with chronic disease Genetic tendency to obesity no barrier to weight management More Scottish GPs needed to fight heart disease (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 11, 2018 Category: UK Health Source Type: news

Evidence does not back primary CVD prevention with statins
Evidence does not support the widespread use of statins in healthy older people to prevent heart disease and stroke, according to the authors of a new Spanish study. (Source: Nursing Times)
Source: Nursing Times - September 7, 2018 Category: Nursing Source Type: news

Study: Statins Don't Help Healthy Seniors' Hearts
Statins were not associated with a reduced risk of heart disease or death from any cause in healthy people over age 75 in a new analysis of data from nearly 47,000 people. (Source: WebMD Health)
Source: WebMD Health - September 6, 2018 Category: Consumer Health News Source Type: news

Widespread Statin Use Not Recommended in Old, Very Old
THURSDAY, Sept. 6, 2018 -- Statin use is not associated with reduced risk of atherosclerotic cardiovascular disease (CVD) or all-cause mortality among older adults without type 2 diabetes, according to a study published online Sept. 5 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 6, 2018 Category: Pharmaceuticals Source Type: news